vs
Healthpeak Properties（DOC）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是Pediatrix Medical Group, Inc.的1.5倍（$719.4M vs $493.8M），Healthpeak Properties净利率更高（73.2% vs 6.8%，领先66.4%），Healthpeak Properties同比增速更快（3.1% vs -1.7%），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -0.1%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
DOC vs MD — 直观对比
营收规模更大
DOC
是对方的1.5倍
$493.8M
营收增速更快
DOC
高出4.8%
-1.7%
净利率更高
DOC
高出66.4%
6.8%
两年增速更快
DOC
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $493.8M |
| 净利润 | $114.0M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | 17.4% | 9.9% |
| 净利率 | 73.2% | 6.8% |
| 营收同比 | 3.1% | -1.7% |
| 净利润同比 | 2406.4% | 10.5% |
| 每股收益（稀释后） | $0.16 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCMD
| Q4 25 | $719.4M | $493.8M | ||
| Q3 25 | $705.9M | $492.9M | ||
| Q2 25 | $694.3M | $468.8M | ||
| Q1 25 | $702.9M | $458.4M | ||
| Q4 24 | $698.0M | $502.4M | ||
| Q3 24 | $700.4M | $511.2M | ||
| Q2 24 | $695.5M | $504.3M | ||
| Q1 24 | $606.6M | $495.1M |
净利润DOCMD
| Q4 25 | $114.0M | $33.7M | ||
| Q3 25 | $-117.1M | $71.7M | ||
| Q2 25 | $31.7M | $39.3M | ||
| Q1 25 | $42.8M | $20.7M | ||
| Q4 24 | $4.5M | $30.5M | ||
| Q3 24 | $85.9M | $19.4M | ||
| Q2 24 | $146.0M | $-153.0M | ||
| Q1 24 | $6.7M | $4.0M |
毛利率DOCMD
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — | ||
| Q1 24 | 59.8% | — |
营业利润率DOCMD
| Q4 25 | 17.4% | 9.9% | ||
| Q3 25 | 9.2% | 13.8% | ||
| Q2 25 | 5.7% | 12.8% | ||
| Q1 25 | 7.7% | 7.0% | ||
| Q4 24 | -2.2% | 7.8% | ||
| Q3 24 | 14.1% | 6.6% | ||
| Q2 24 | 22.3% | -31.3% | ||
| Q1 24 | 3.7% | 3.2% |
净利率DOCMD
| Q4 25 | 73.2% | 6.8% | ||
| Q3 25 | -16.6% | 14.5% | ||
| Q2 25 | 4.6% | 8.4% | ||
| Q1 25 | 6.1% | 4.5% | ||
| Q4 24 | 0.7% | 6.1% | ||
| Q3 24 | 12.3% | 3.8% | ||
| Q2 24 | 21.0% | -30.3% | ||
| Q1 24 | 1.1% | 0.8% |
每股收益（稀释后）DOCMD
| Q4 25 | $0.16 | $0.40 | ||
| Q3 25 | $-0.17 | $0.84 | ||
| Q2 25 | $0.05 | $0.46 | ||
| Q1 25 | $0.06 | $0.24 | ||
| Q4 24 | $0.02 | $0.37 | ||
| Q3 24 | $0.12 | $0.23 | ||
| Q2 24 | $0.21 | $-1.84 | ||
| Q1 24 | $0.01 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $375.2M |
| 总债务越低越好 | $9.8B | $570.5M |
| 股东权益账面价值 | $7.5B | $865.9M |
| 总资产 | $20.3B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.31× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资DOCMD
| Q4 25 | $467.5M | $375.2M | ||
| Q3 25 | $91.0M | $340.1M | ||
| Q2 25 | $89.4M | $224.7M | ||
| Q1 25 | $70.6M | $99.0M | ||
| Q4 24 | $119.8M | $229.9M | ||
| Q3 24 | $180.4M | $103.8M | ||
| Q2 24 | $106.9M | $19.4M | ||
| Q1 24 | $101.8M | $8.0M |
总债务DOCMD
| Q4 25 | $9.8B | $570.5M | ||
| Q3 25 | $9.1B | $577.2M | ||
| Q2 25 | $9.0B | $583.9M | ||
| Q1 25 | $8.9B | $590.5M | ||
| Q4 24 | $8.7B | $597.1M | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCMD
| Q4 25 | $7.5B | $865.9M | ||
| Q3 25 | $7.6B | $890.7M | ||
| Q2 25 | $7.9B | $833.8M | ||
| Q1 25 | $8.2B | $789.2M | ||
| Q4 24 | $8.4B | $764.9M | ||
| Q3 24 | $8.6B | $732.5M | ||
| Q2 24 | $8.8B | $706.5M | ||
| Q1 24 | $8.9B | $856.2M |
总资产DOCMD
| Q4 25 | $20.3B | $2.2B | ||
| Q3 25 | $19.6B | $2.2B | ||
| Q2 25 | $19.8B | $2.1B | ||
| Q1 25 | $19.8B | $2.0B | ||
| Q4 24 | $19.9B | $2.2B | ||
| Q3 24 | $20.0B | $2.1B | ||
| Q2 24 | $20.2B | $2.0B | ||
| Q1 24 | $20.5B | $2.2B |
负债/权益比DOCMD
| Q4 25 | 1.31× | 0.66× | ||
| Q3 25 | 1.20× | 0.65× | ||
| Q2 25 | 1.14× | 0.70× | ||
| Q1 25 | 1.08× | 0.75× | ||
| Q4 24 | 1.04× | 0.78× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | — |
| 自由现金流率自由现金流/营收 | 49.6% | — |
| 资本支出强度资本支出/营收 | 124.4% | — |
| 现金转化率经营现金流/净利润 | 10.99× | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCMD
| Q4 25 | $1.3B | $114.1M | ||
| Q3 25 | $315.0M | $137.3M | ||
| Q2 25 | $363.5M | $137.2M | ||
| Q1 25 | $279.4M | $-117.5M | ||
| Q4 24 | $1.1B | $133.0M | ||
| Q3 24 | $318.2M | $91.8M | ||
| Q2 24 | $316.2M | $107.0M | ||
| Q1 24 | $152.6M | $-125.2M |
自由现金流DOCMD
| Q4 25 | $357.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $333.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率DOCMD
| Q4 25 | 49.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DOCMD
| Q4 25 | 124.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 105.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率DOCMD
| Q4 25 | 10.99× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 11.48× | 3.49× | ||
| Q1 25 | 6.52× | -5.66× | ||
| Q4 24 | 235.43× | 4.36× | ||
| Q3 24 | 3.71× | 4.72× | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | 22.85× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
